Translational value of choroid plexus imaging for tracking neuroinflammation in mice and humans.
Adult
Animals
Blood-Brain Barrier
/ physiology
Brain
/ physiology
Choroid Plexus
/ diagnostic imaging
Disease Models, Animal
Encephalomyelitis, Autoimmune, Experimental
/ physiopathology
Female
Humans
Magnetic Resonance Imaging
/ methods
Male
Mice
Mice, Inbred C57BL
Multiple Sclerosis
/ diagnostic imaging
Neuroinflammatory Diseases
/ diagnostic imaging
Proteomics
/ methods
choroid plexus
disease activity
multiple sclerosis
neuroinflammation
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
07 09 2021
07 09 2021
Historique:
accepted:
28
07
2021
received:
06
08
2021
entrez:
4
9
2021
pubmed:
5
9
2021
medline:
5
1
2022
Statut:
ppublish
Résumé
Neuroinflammation is a pathophysiological hallmark of multiple sclerosis and has a close mechanistic link to neurodegeneration. Although this link is potentially targetable, robust translatable models to reliably quantify and track neuroinflammation in both mice and humans are lacking. The choroid plexus (ChP) plays a pivotal role in regulating the trafficking of immune cells from the brain parenchyma into the cerebrospinal fluid (CSF) and has recently attracted attention as a key structure in the initiation of inflammatory brain responses. In a translational framework, we here address the integrity and multidimensional characteristics of the ChP under inflammatory conditions and question whether ChP volumes could act as an interspecies marker of neuroinflammation that closely interrelates with functional impairment. Therefore, we explore ChP characteristics in neuroinflammation in patients with multiple sclerosis and in two experimental mouse models, cuprizone diet-related demyelination and experimental autoimmune encephalomyelitis. We demonstrate that ChP enlargement-reconstructed from MRI-is highly associated with acute disease activity, both in the studied mouse models and in humans. A close dependency of ChP integrity and molecular signatures of neuroinflammation is shown in the performed transcriptomic analyses. Moreover, pharmacological modulation of the blood-CSF barrier with natalizumab prevents an increase of the ChP volume. ChP enlargement is strongly linked to emerging functional impairment as depicted in the mouse models and in multiple sclerosis patients. Our findings identify ChP characteristics as robust and translatable hallmarks of acute and ongoing neuroinflammatory activity in mice and humans that could serve as a promising interspecies marker for translational and reverse-translational approaches.
Identifiants
pubmed: 34479997
pii: 2025000118
doi: 10.1073/pnas.2025000118
pmc: PMC8433504
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Déclaration de conflit d'intérêts
The authors declare no competing interest.
Références
Science. 2014 Oct 3;346(6205):89-93
pubmed: 25147279
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2264-9
pubmed: 23335631
PLoS One. 2015 Mar 27;10(3):e0121738
pubmed: 25815836
Mult Scler. 2016 May;22(6):770-81
pubmed: 26362893
J Neuroinflammation. 2020 Jun 12;17(1):186
pubmed: 32532336
J Clin Invest. 1994 Nov;94(5):1722-8
pubmed: 7525645
J Alzheimers Dis. 2020;74(4):1057-1068
pubmed: 32144979
Acta Neuropathol Commun. 2017 Dec 01;5(1):94
pubmed: 29195512
Fluids Barriers CNS. 2018 Dec 12;15(1):34
pubmed: 30541599
J Neuroimmunol. 2002 Sep;130(1-2):32-45
pubmed: 12225886
PLoS One. 2015 Aug 12;10(8):e0135428
pubmed: 26267665
Acta Neuropathol. 2017 Apr;133(4):597-612
pubmed: 28184993
Neuroradiol J. 2017 Oct;30(5):490-495
pubmed: 28644061
Brain Res. 2020 Oct 15;1745:146950
pubmed: 32524994
Nat Immunol. 2009 May;10(5):514-23
pubmed: 19305396
Neurology. 2016 Jan 19;86(3):286-96
pubmed: 26683646
Ernst Schering Res Found Workshop. 2004;(47):17-38
pubmed: 15032052
Nat Med. 2017 Aug;23(8):997-1003
pubmed: 28692063
Cells. 2020 Mar 31;9(4):
pubmed: 32244377
Sci Transl Med. 2012 Aug 15;4(147):147ra111
pubmed: 22896675
Acta Neuropathol. 2012 Aug;124(2):209-20
pubmed: 22688405
J Alzheimers Dis. 2018;62(4):1691-1702
pubmed: 29614677
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Bioinformatics. 2018 Sep 1;34(17):i884-i890
pubmed: 30423086
Multivariate Behav Res. 2011 Feb 7;46(1):1-32
pubmed: 26771579
Methods Mol Biol. 2010;633:207-20
pubmed: 20204630
Acta Neuropathol. 2009 Oct;118(4):497-504
pubmed: 19597827
J Comp Neurol. 2007 May 10;502(2):236-60
pubmed: 17348011
PLoS One. 2008 Jul 30;3(7):e2829
pubmed: 18665237
Neuroscience. 2019 Apr 1;403:35-53
pubmed: 29101079
Ann Neurol. 2020 Sep;88(3):562-573
pubmed: 32418239
PLoS One. 2008 Aug 22;3(8):e3037
pubmed: 18725947
J Neurosci Res. 2020 May;98(5):751-753
pubmed: 31825126
PLoS One. 2014 Sep 11;9(9):e106592
pubmed: 25211495
Brain Behav Immun. 2013 Nov;34:11-6
pubmed: 23597431
Exp Neurol. 2015 Nov;273:57-68
pubmed: 26247808
Microsc Res Tech. 2001 Jan 1;52(1):112-29
pubmed: 11135454
BMC Neurol. 2016 Apr 12;16:47
pubmed: 27067000
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8389-94
pubmed: 12829791
Science. 2016 Aug 19;353(6301):766-71
pubmed: 27540163
J Clin Invest. 2010 May;120(5):1368-79
pubmed: 20440079
J Neuroinflammation. 2012 Aug 07;9:187
pubmed: 22870891
J Neuroinflammation. 2018 Aug 22;15(1):236
pubmed: 30134924
N Engl J Med. 2006 Mar 2;354(9):899-910
pubmed: 16510744
JCI Insight. 2020 Nov 5;5(21):
pubmed: 33148886
Cells. 2019 Jan 28;8(2):
pubmed: 30696113
Br J Pharmacol. 2010 Aug;160(7):1577-9
pubmed: 20649561
J Nucl Med. 2019 Oct;60(10):1444-1451
pubmed: 30877180
Sci Rep. 2015 Sep 21;5:14329
pubmed: 26388497
Acta Neuropathol Commun. 2020 Feb 3;8(1):9
pubmed: 32014066
Neurobiol Dis. 2017 Nov;107:32-40
pubmed: 27546055
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
Mult Scler. 2019 Nov;25(13):1781-1790
pubmed: 30334474
Neurol Neuroimmunol Neuroinflamm. 2020 Feb 5;7(3):
pubmed: 32024782
Lancet Neurol. 2015 Feb;14(2):183-93
pubmed: 25772897
J Clin Invest. 2013 Mar;123(3):1299-309
pubmed: 23434588
Childs Nerv Syst. 1995 Sep;11(9):511-6
pubmed: 8529217
J Neuroimmunol. 2008 Aug 13;199(1-2):133-41
pubmed: 18539342
J Immunol. 2010 Oct 15;185(8):4846-55
pubmed: 20861356
Nature. 2015 Jul 16;523(7560):337-41
pubmed: 26030524
Lancet Neurol. 2014 Aug;13(8):807-22
pubmed: 25008549
J Neuropathol Exp Neurol. 2016 Mar;75(3):198-213
pubmed: 26888305
Prog Neurobiol. 2019 Nov;182:101663
pubmed: 31374243
J Neurol. 2019 Feb;266(2):386-397
pubmed: 30515631
Nat Med. 2013 Sep;19(9):1161-5
pubmed: 23933981
Ann Clin Transl Neurol. 2018 Dec 09;6(2):252-262
pubmed: 30847358
Neurol Neuroimmunol Neuroinflamm. 2018 Mar 01;5(3):e446
pubmed: 29511705
Nature. 1992 Mar 5;356(6364):63-6
pubmed: 1538783
Proc Natl Acad Sci U S A. 2018 May 22;115(21):5528-5533
pubmed: 29728463
J Neuroimmunol. 2011 Jun;235(1-2):70-6
pubmed: 21550672
Eur J Immunol. 2018 Aug;48(8):1308-1318
pubmed: 29697861
Brain. 2016 Jan;139(Pt 1):115-26
pubmed: 26637488
Neurol Neuroimmunol Neuroinflamm. 2017 Oct 11;4(6):e401
pubmed: 29075657
Trends Immunol. 2005 Sep;26(9):485-95
pubmed: 16039904
Neurosci Biobehav Rev. 2014 Nov;47:485-505
pubmed: 25445182
World J Biol Psychiatry. 2021 Feb;22(2):104-118
pubmed: 32306867
Ther Adv Neurol Disord. 2019 Jun 27;12:1756286419859722
pubmed: 31275430
Mult Scler. 2019 Mar;25(3):338-343
pubmed: 29226779
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Am J Psychiatry. 2019 Jul 1;176(7):564-572
pubmed: 31164007
Nature. 2009 Nov 5;462(7269):94-8
pubmed: 19829296
Neuroimage. 2012 Aug 15;62(2):774-81
pubmed: 22248573
Brain. 1997 Nov;120 ( Pt 11):2059-69
pubmed: 9397021
Histochem Cell Biol. 2019 Aug;152(2):119-131
pubmed: 31016368